Molecules blocking a receptor found in the brain called 5-HT6R could potentially be used to treat Alzheimer’s disease, according to…
Özge Özkaya, PhD
Özge has a MSc. in Molecular Genetics from the University of Leicester and a PhD in Developmental Biology from Queen Mary University of London. She worked as a Post-doctoral Research Associate at the University of Leicester for six years in the field of Behavioural Neurology before moving into science communication. She worked as the Research Communication Officer at a London based charity for almost two years.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Özge Özkaya, PhD
Women perform better than men on all memory measures but these sex differences tend to disappear as women age and enter menopause, according to a study published in the journal Menopause. These findings highlights the importance of ovarian hormones in maintaining memory function and could explain the reason why women are almost twice as likely as men to develop Alzheimer’s disease.
Scientists identified two new genes associated with the risk of developing Alzheimer’s disease (AD) in African-Americans. According to the researcher, this new discovery could lead to the development of new drugs that target these genes for the treatment of AD.